ExPert ConsEnsus on the management of Advanced clear-cell RenaL celL carcinoma: INDIAn Perspective (PEARL-INDIA)

In advanced Renal Cell Carcinoma (aRCC), systemic therapy is the mainstay of treatment, with no or little role for surgery in these patients. Tyrosine kinase inhibitors (TKIs) and immune-oncological (IOs) therapies, either alone or in combination, are recommended in these patients depending on patie...

Descripción completa

Detalles Bibliográficos
Autores principales: Sahoo, Tarini Prasad, Desai, Chirag, Agarwal, Shyam, Rauthan, Amit, Dhabhar, Boman, Biswas, Ghanshyam, Batra, Sandeep, Saha, Rajat, Philip, Arun, Agarwal, Vijay, Dattatreya, Palanki Satya, Mohapatra, PN, Deshmukh, Chetan, Bhagat, Sagar, Patil, Saiprasad, Barkate, Hanmant
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10413514/
https://www.ncbi.nlm.nih.gov/pubmed/37558975
http://dx.doi.org/10.1186/s12885-023-11237-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10413514/
https://www.ncbi.nlm.nih.gov/pubmed/37558975
http://dx.doi.org/10.1186/s12885-023-11237-y

Ejemplares similares